BRIEF—Takeda updates forecasts following Shire deal

Japanese drugmaker Takeda (TYO: 4502) has revised its forecasts for the year ended March 31, to account for its $62 billion takeover of Shire.

The firm now expects its operating profit to be 205 billion yen ($1.8 billion), where the previous estimate was 268.9 billion yen, representing a 24% drop. The cost incurred from the Shire takeover came in at 126 billion yen.

In issuing the guidance, Takeda gave figures relating to expected profits from its own standalone operations – raising its operating profit forecast by 47% for the year due to increased drug sales and efficiencies, and lifting its revenue outlook by 2.2%. The revenue guidance for the combined company was raised by 20% to 1,788 billion yen.